These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 33775833)

  • 1. Discovery of an indole-substituted furanone with tubulin polymerization inhibition activity.
    Mowery P; Filkorn MM; Hurysz B; Kwansare DO; Lafferty MM; McFadden MA; Neerukonda ND; Patel RR; Pierce K; Sockett KA; Truax NJ; Webster NR; Pelkey ET
    Bioorg Med Chem Lett; 2021 Jun; 41():127991. PubMed ID: 33775833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis, in vitro and in vivo biological evaluation of 2-amino-3-aroylbenzo[b]furan derivatives as highly potent tubulin polymerization inhibitors.
    Oliva P; Romagnoli R; Manfredini S; Brancale A; Ferla S; Hamel E; Ronca R; Maccarinelli F; Giacomini A; Rruga F; Mariotto E; Viola G; Bortolozzi R
    Eur J Med Chem; 2020 Aug; 200():112448. PubMed ID: 32417696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New 6- and 7-heterocyclyl-1H-indole derivatives as potent tubulin assembly and cancer cell growth inhibitors.
    La Regina G; Bai R; Coluccia A; Naccarato V; Famiglini V; Nalli M; Masci D; Verrico A; Rovella P; Mazzoccoli C; Da Pozzo E; Cavallini C; Martini C; Vultaggio S; Dondio G; Varasi M; Mercurio C; Hamel E; Lavia P; Silvestri R
    Eur J Med Chem; 2018 May; 152():283-297. PubMed ID: 29730191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of indoline derivatives as anticancer agents via inhibition of tubulin polymerization.
    Wang SY; Liu X; Meng LW; Li MM; Li YR; Yu GX; Song J; Zhang HY; Chen P; Zhang SY; Hu T
    Bioorg Med Chem Lett; 2021 Jul; 43():128095. PubMed ID: 33965530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure modification and biological evaluation of indole-chalcone derivatives as anti-tumor agents through dual targeting tubulin and TrxR.
    Yan J; Xu Y; Jin X; Zhang Q; Ouyang F; Han L; Zhan M; Li X; Liang B; Huang X
    Eur J Med Chem; 2022 Jan; 227():113897. PubMed ID: 34649064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Indole molecules as inhibitors of tubulin polymerization: potential new anticancer agents.
    Patil SA; Patil R; Miller DD
    Future Med Chem; 2012 Oct; 4(16):2085-115. PubMed ID: 23157240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis and biological evaluation of 2-alkoxycarbonyl-3-anilinoindoles as a new class of potent inhibitors of tubulin polymerization.
    Romagnoli R; Prencipe F; Oliva P; Kimatrai Salvador M; Brancale A; Ferla S; Hamel E; Viola G; Bortolozzi R; Persoons L; Balzarini J; Liekens S; Schols D
    Bioorg Chem; 2020 Apr; 97():103665. PubMed ID: 32086053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of new 3-phenyl-1H-indole-2-carbohydrazide derivatives and their structure-activity relationships as potent tubulin inhibitors and anticancer agents: A combined in silico, in vitro and synthetic study.
    Saruengkhanphasit R; Butkinaree C; Ornnork N; Lirdprapamongkol K; Niwetmarin W; Svasti J; Ruchirawat S; Eurtivong C
    Bioorg Chem; 2021 May; 110():104795. PubMed ID: 33730670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Indole molecules as inhibitors of tubulin polymerization: potential new anticancer agents, an update (2013-2015).
    Patil R; Patil SA; Beaman KD; Patil SA
    Future Med Chem; 2016 Jul; 8(11):1291-316. PubMed ID: 27476704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-Arylsulfonylsubstituted-1H indole derivatives as small molecule dual inhibitors of signal transducer and activator of transcription 3 (STAT3) and tubulin.
    Zhou Q; Zhu J; Chen J; Ji P; Qiao C
    Bioorg Med Chem; 2018 Jan; 26(1):96-106. PubMed ID: 29174507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 2-Alkoxycarbonyl-3-arylamino-5-substituted thiophenes as a novel class of antimicrotubule agents: Design, synthesis, cell growth and tubulin polymerization inhibition.
    Romagnoli R; Kimatrai Salvador M; Schiaffino Ortega S; Baraldi PG; Oliva P; Baraldi S; Lopez-Cara LC; Brancale A; Ferla S; Hamel E; Balzarini J; Liekens S; Mattiuzzo E; Basso G; Viola G
    Eur J Med Chem; 2018 Jan; 143():683-698. PubMed ID: 29220790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis and biological evaluation of a series of pyrano chalcone derivatives containing indole moiety as novel anti-tubulin agents.
    Wang G; Li C; He L; Lei K; Wang F; Pu Y; Yang Z; Cao D; Ma L; Chen J; Sang Y; Liang X; Xiang M; Peng A; Wei Y; Chen L
    Bioorg Med Chem; 2014 Apr; 22(7):2060-79. PubMed ID: 24629450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery and optimization of 3,4,5-trimethoxyphenyl substituted triazolylthioacetamides as potent tubulin polymerization inhibitors.
    Yang F; He CP; Diao PC; Hong KH; Rao JJ; Zhao PL
    Bioorg Med Chem Lett; 2019 Jan; 29(1):22-27. PubMed ID: 30448234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticancer properties of indole derivatives as IsoCombretastatin A-4 analogues.
    Pecnard S; Hamze A; Bignon J; Prost B; Deroussent A; Gallego-Yerga L; Peláez R; Paik JY; Diederich M; Alami M; Provot O
    Eur J Med Chem; 2021 Nov; 223():113656. PubMed ID: 34171660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and biological evaluation of novel indole-pyrimidine hybrids bearing morpholine and thiomorpholine moieties.
    Diao PC; Li Q; Hu MJ; Ma YF; You WW; Hong KH; Zhao PL
    Eur J Med Chem; 2017 Jul; 134():110-118. PubMed ID: 28410492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of certain benzyl/phenethyl thiazolidinone-indole hybrids as potential anti-proliferative agents: Synthesis, molecular modeling and tubulin polymerization inhibition study.
    Sigalapalli DK; Pooladanda V; Singh P; Kadagathur M; Guggilapu SD; Uppu JL; Tangellamudi ND; Gangireddy PK; Godugu C; Bathini NB
    Bioorg Chem; 2019 Nov; 92():103188. PubMed ID: 31450167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of novel tubulin inhibitors targeting the colchicine binding site via virtual screening, structural optimization and antitumor evaluation.
    Liu W; Jia H; Guan M; Cui M; Lan Z; He Y; Guo Z; Jiang R; Dong G; Wang S
    Bioorg Chem; 2022 Jan; 118():105486. PubMed ID: 34801948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design and synthesis of novel 5-(4-chlorophenyl)furan derivatives with inhibitory activity on tubulin polymerization.
    Moussa SA; A Osman EE; Eid NM; Abou-Seri SM; El Moghazy SM
    Future Med Chem; 2018 Aug; 10(16):1907-1924. PubMed ID: 29966433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of highly potent tubulin polymerization inhibitors: Design, synthesis, and structure-activity relationships of novel 2,7-diaryl-[1,2,4]triazolo[1,5-a]pyrimidines.
    Huo XS; Jian XE; Ou-Yang J; Chen L; Yang F; Lv DX; You WW; Rao JJ; Zhao PL
    Eur J Med Chem; 2021 Aug; 220():113449. PubMed ID: 33895499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of GA-MLR for QSAR Modeling of the Arylthioindole Class of Tubulin Polymerization Inhibitors as Anticancer Agents.
    Ahmadi S; Habibpour E
    Anticancer Agents Med Chem; 2017; 17(4):552-565. PubMed ID: 27528182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.